Location of Repository

Beta blocker use in subjects with type 2 diabetes mellitus and systolic heart failure does not worsen glycaemic control

By Bryan Wai, Leighton G Kearney, David L Hare, Michelle Ord, Louise M Burrell and Piyush M Srivastava
Topics: Original Investigation
Publisher: BioMed Central
OAI identifier: oai:pubmedcentral.nih.gov:3298480
Provided by: PubMed Central
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://www.pubmedcentral.nih.g... (external link)
  • Suggested articles

    Preview

    Citations

    1. (2005). al: Differential effects of betablockers on albuminuria in patients with type 2 diabetes. Hypertension
    2. (2005). Anker SD: Impaired insulin sensitivity as an independent risk factor for mortality in patients with stable chronic heart failure.
    3. (2003). Are beta-blockers as efficacious in patients with diabetes mellitus as in patients without diabetes mellitus who have chronic heart failure? A meta-analysis of large-scale clinical trials. Am Heart J
    4. (2002). ASHP therapeutic position statement on the use of beta-blockers in survivors of acute myocardial infarction.
    5. (2008). Beta-blockers have a beneficial effect upon endothelial function and microalbuminuria in African-American subjects with diabetes and hypertension.
    6. (2003). de Zeeuw D: Screening for microalbuminuria in the general population: a tool to detect subjects at risk for progressive renal failure in an early phase? Nephrol Dial Transplant
    7. (2008). Diabetes, left ventricular systolic dysfunction, and chronic heart failure. Eur Heart J
    8. (2011). Endothelial function is unaffected by changing between carvedilol and metoprolol in patients with heart failure-a randomized study. Cardiovasc Diabetol
    9. (2007). et al: Differential effect of betablocker therapy on insulin resistance as a function of insulin sensitizer use: results from GEMINI. Diabet Med
    10. (2001). et al: Effect of carvedilol on survival in severe chronic heart failure.
    11. (2004). et al: Metabolic effects of carvedilol vs metoprolol in patients with type 2 diabetes mellitus and hypertension: a randomized controlled trial. Jama
    12. (2002). et al: Microalbuminuria in the US population: third National Health and Nutrition Examination Survey.
    13. (1996). GJ: Differential effect of chronic treatment with two beta-blocking agents on insulin sensitivity: the carvedilol-metoprolol study.
    14. (2001). Glycemic control and heart failure among adult patients with diabetes. Circulation
    15. (2000). Holman RR: Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. Bmj
    16. (2009). JB: Comparison of carvedilol and metoprolol on serum lipid concentration in diabetic hypertensive patients. Diabetes Obes Metab
    17. (2006). LM: Diastolic dysfunction is associated with anaemia in patients with Type II diabetes. Clin Sci (Lond)
    18. (2010). Metoprolol compared to carvedilol deteriorates insulin-stimulated endothelial function in patients with type 2 diabetes - a randomized study. Cardiovasc Diabetol
    19. (2007). Prescription patterns in patients with systolic heart failure at hospital discharge: why beta blockers are underprescribed or prescribed at low dose in real life? Int J Clin Pract
    20. (2003). Prevention of Heart Failure in Patients in the Heart Outcomes Prevention Evaluation (HOPE) Study. Circulation
    21. (1989). Sensitivity to insulin during treatment with atenolol and metoprolol: a randomised, double blind study of effects on carbohydrate and lipoprotein metabolism in hypertensive patients. Bmj
    22. (2003). Sowers JR: Heart failure in diabetic patients: utility of beta-blockade.

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.